Assignee
ALPINE IMMUNE SCIENCES INC
US·27 granted patents·21 pending applications·116 citations·filing 2016–2025
Top patents by PatentIndex Score
48 records- 0198US11230588B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Jan 25, 2022·6 cites·29 claims
- 0298US11117949B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·30 claims
- 0398US11117950B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·28 claims
- 0498US11117948B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·30 claims
- 0598US11096988B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Aug 24, 2021·13 cites·19 claims
- 0697US11078282B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Aug 3, 2021·17 cites·33 claims
- 0795US11359022B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Jun 14, 2022·2 cites·19 claims
- 0895US11319359B2Immunomodulatory proteins with tunable affinitiesALPINE IMMUNE SCIENCES INC·Filed 2016·Granted May 3, 2022·9 cites·12 claims
- 0994US11639375B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Granted May 2, 2023·4 cites·28 claims
- 1094US11498967B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Granted Nov 15, 2022·2 cites·24 claims
- 1194US11479609B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Granted Oct 25, 2022·2 cites·18 claims
- 1294US10882914B2ICOS ligand variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Jan 5, 2021·8 cites·45 claims
- 1393US11753458B2CTLA-4 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Granted Sep 12, 2023·6 cites·31 claims
- 1493US11274140B2APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Mar 15, 2022·2 cites·30 claims
- 1591US11613566B2Variant ICOS ligand immunomodulatory proteins and related compositions and methodsALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Mar 28, 2023·1 cites·4 claims
- 1690US12304943B2April and BAFF inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Granted May 20, 2025·0 cites·5 claims
- 1786US12358969B2CTLA-4 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2023·Granted Jul 15, 2025·0 cites·37 claims
- 1885US2025019413A1April and baff inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Application pending·0 cites
- 1985US2025019412A1April and baff inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Application pending·0 cites
- 2083US12065476B2PD-1 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2019·Granted Aug 20, 2024·2 cites·11 claims
- 2183US2025320272A1Ctla-4 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2025·Application pending·0 cites
- 2282US2024409660A1Icos ligand variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Application pending·0 cites
- 2382US2024002466A1Cd80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 2481US2023136723A1Cd80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2581US2024218045A1April and baff inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 2679US2023250152A1Ctla-4 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 2778US11471488B2CD155 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Oct 18, 2022·1 cites·22 claims
- 2877US11732022B2PD-L2 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Granted Aug 22, 2023·1 cites·9 claims
- 2977US2024360197A1Pd-1 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2024·Application pending·0 cites
- 3076US12202882B2APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Jan 21, 2025·0 cites·21 claims
- 3176US2023235012A1Variant icos ligand immunomodulatory proteins and related compositions and methodsALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 3274US12486312B2Immunomodulatory proteins with tunable affinitiesALPINE IMMUNE SCIENCES INC·Filed 2022·Granted Dec 2, 2025·0 cites·25 claims
- 3373US11834490B2CD112 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Dec 5, 2023·1 cites·35 claims
- 3472US12110339B2ICOS ligand variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2020·Granted Oct 8, 2024·0 cites·21 claims
- 3569US2026062456A1Pd-l1 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2025·Application pending·0 cites
- 3664US12297253B2Multi-domain immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2019·Granted May 13, 2025·0 cites·37 claims
- 3763US2025243260A1Immunomodulatory proteins of variant cd80 polypeptides, cell therapies and related methods and usesALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 3861US2020283500A1Variant icos ligand immunomodulatory proteins and related compositions and methodsALPINE IMMUNE SCIENCES INC·Filed 2018·Application pending·0 cites
- 3961US2023381229A1Cd155 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Application pending·0 cites
- 4060US2025163127A1Multi-domain immunomodulatory proteins and methods of use thereofALPINE IMMUNE SCIENCES INC·Filed 2025·Application pending·0 cites
- 4159US2024279310A1Methods of dosing and treatment with a taci-fc fusion immunomodulatory proteinALPINE IMMUNE SCIENCES INC·Filed 2022·Application pending·0 cites
- 4255US2023220039A1Pd-l1 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Application pending·0 cites
- 4347US2022177587A1Methods and uses of variant cd80 fusion proteins and related constructsALPINE IMMUNE SCIENCES INC·Filed 2019·Application pending·0 cites
- 4446US12552853B2CD86 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2019·Granted Feb 17, 2026·0 cites·23 claims
- 4546US10399946B2Solid forms of an S-Nitrosoglutathione reductase inhibitorALPINE IMMUNE SCIENCES INC·Filed 2016·Granted Sep 3, 2019·0 cites·16 claims
- 4646US2022218785A1Methods and uses of variant icos ligand (icosl) fusion proteinsALPINE IMMUNE SCIENCES INC·Filed 2020·Application pending·0 cites
- 4742US2020040059A1Secretable variant immunomodulatory proteins and engineered cell therapyALPINE IMMUNE SCIENCES INC·Filed 2017·Application pending·0 cites
- 4839US2018256644A1Tunable variant immunoglobulin superfamily domains and engineered cell therapyALPINE IMMUNE SCIENCES INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ALPINE IMMUNE SCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →